Did you suffer investment losses with Robotti Securities (a/k/a Robotti & Company, Robotti & Eng) (CRD# 13251) (SEC# 8-28886)?
Galvin Legal, PLLC is launching an investigation on behalf of investors who may have suffered losses investing with Robotti Securities (a/k/a Robotti & Company, Robotti & Eng). If you suffered losses investing with Robotti Securities (a/k/a Robotti & Company, Robotti & Eng), then Galvin Legal, PLLC may be able to help you recover your losses in a Financial Industry Regulatory Authority (“FINRA“) arbitration claim.
If you suffered losses and would like a free consultation with a securities attorney, then please call Galvin Legal, PLLC at 1-800-405-5117.
As of July 7, 2020, Robotti Securities (a/k/a Robotti & Company, Robotti & Eng)’s FINRA BrokerCheck Report contains the following:
2 Regulatory Event Disclosures
Main Office Location
60 EAST 42ND ST.
SUITE 3100
NEW YORK, NY 10165
UNITED STATES
Mailing Address
60 EAST 42ND ST.
SUITE 3100
NEW YORK, NY 10165
UNITED STATES
Business Telephone Number
(202) 986-4800
If you suffered losses and would like a free consultation with a securities attorney, then please call Galvin Legal, PLLC at 1-800-405-5117.
Robotti Securities (a/k/a Robotti & Company, Robotti & Eng)’s Direct Owners and Executive Officers
ROBOTTI & COMPANY, INCORPORATED, STOCKHOLDER 100% OWNER OF APPLICANT
KELLEHER, DENNIS MICHAEL (CRD#:2107342), CHIEF COMPLIANCE OFFICER
MCQUEENEY, DAVID VINCENT (CRD#:2440806), SROP, ROP
MEVORAH, ERWIN I (CRD#:1944735), CFO, FIN/OP & SECRETARY
ROBOTTI, ROBERT EDWARD (CRD#:732905), PRESIDENT, CEO, GSP, TREASURER
ROBOTTI, SUZANNE BENSON (CRD#:4616454), DIRECTOR
SEKLIR, NANCY ELIZABETH (CRD#:1756843), DIRECTOR
WASIAK, KENNETH RONALD (CRD#:1485703), DIRECTOR
WIEGAND, JEFFREY PHILLIPS (CRD#:1384821), SROP, ROP
If you suffered losses and would like a free consultation with a securities attorney, then please call Galvin Legal, PLLC at 1-800-405-5117.
Due Diligence Requirement
FINRA requires broker-dealers to conduct due diligence on investments and to conduct a suitability analysis when recommending securities to a customer that takes into account the customer’s knowledge and experience. FINRA Rule 2111(a) states that “a member or an associated person must have a reasonable basis to believe that a recommended transaction or investment strategy involving a security or securities is suitable for the customer, based on the information obtained through the reasonable diligence of the member or associated person to ascertain the customer’s investment profile. A customer’s investment profile includes, but is not limited to, the customer’s age, other investments, financial situation and needs, tax status, investment objectives, investment experience, investment time horizon, liquidity needs, risk tolerance, and any other information the customer may disclose to the member or associated person in connection with such recommendation.”
Rule 2111 is composed of three main obligations: reasonable-basis suitability, customer-specific suitability, and quantitative suitability. Broker-Dealers that fail to conduct adequate due diligence on investments they recommend or that make unsuitable recommendations can be held responsible for the customer’s losses in a FINRA arbitration claim.
If you suffered losses and would like a free consultation with a securities attorney, then please call Galvin Legal, PLLC at 1-800-405-5117.
Request a Free Consultation with a Securities Attorney
If you suffered losses investing with Robotti Securities (a/k/a Robotti & Company, Robotti & Eng) and would like a free consultation with a securities attorney, then please call Galvin Legal, PLLC at 1-800-405-5117.
This information is all publicly available and is being provided to you by Galvin Legal, PLLC.
Galvin Legal, PLLC is a national securities arbitration, securities mediation, securities litigation, securities fraud, securities regulation and compliance, and investor protection law practice. For more information on Galvin Legal, PLLC and its representation of investors, please visit www.galvinlegal.com or call 1-800-405-5117.
